IOL CHEMICALS & PHARM. | DR. REDDYS LAB | IOL CHEMICALS & PHARM./ DR. REDDYS LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 19.9 | 68.6% | View Chart |
P/BV | x | 1.6 | 4.5 | 34.7% | View Chart |
Dividend Yield | % | 1.0 | 0.6 | 155.8% |
IOL CHEMICALS & PHARM. DR. REDDYS LAB |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
DR. REDDYS LAB Mar-23 |
IOL CHEMICALS & PHARM./ DR. REDDYS LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 4,656 | 11.5% | |
Low | Rs | 272 | 3,788 | 7.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 1,481.4 | 25.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 270.7 | 8.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 345.7 | 9.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 40.00 | 10.0% | |
Avg Dividend yield | % | 1.0 | 0.9 | 104.4% | |
Book value per share (Unadj.) | Rs | 256.8 | 1,389.6 | 18.5% | |
Shares outstanding (eoy) | m | 58.71 | 166.53 | 35.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.8 | 37.6% | |
Avg P/E ratio | x | 17.1 | 15.6 | 109.4% | |
P/CF ratio (eoy) | x | 12.8 | 12.2 | 104.9% | |
Price / Book Value ratio | x | 1.6 | 3.0 | 51.8% | |
Dividend payout | % | 16.9 | 14.8 | 114.2% | |
Avg Mkt Cap | Rs m | 23,743 | 703,039 | 3.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 46,466 | 3.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 246,697 | 9.0% | |
Other income | Rs m | 256 | 10,555 | 2.4% | |
Total revenues | Rs m | 22,427 | 257,252 | 8.7% | |
Gross profit | Rs m | 2,257 | 63,860 | 3.5% | |
Depreciation | Rs m | 462 | 12,502 | 3.7% | |
Interest | Rs m | 165 | 1,428 | 11.5% | |
Profit before tax | Rs m | 1,887 | 60,485 | 3.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 15,412 | 3.2% | |
Profit after tax | Rs m | 1,391 | 45,073 | 3.1% | |
Gross profit margin | % | 10.2 | 25.9 | 39.3% | |
Effective tax rate | % | 26.2 | 25.5 | 103.0% | |
Net profit margin | % | 6.3 | 18.3 | 34.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 203,161 | 4.8% | |
Current liabilities | Rs m | 5,025 | 85,721 | 5.9% | |
Net working cap to sales | % | 20.9 | 47.6 | 44.0% | |
Current ratio | x | 1.9 | 2.4 | 81.2% | |
Inventory Days | Days | 43 | 79 | 54.6% | |
Debtors Days | Days | 8 | 107 | 7.8% | |
Net fixed assets | Rs m | 11,017 | 112,638 | 9.8% | |
Share capital | Rs m | 587 | 833 | 70.5% | |
"Free" reserves | Rs m | 14,490 | 230,571 | 6.3% | |
Net worth | Rs m | 15,077 | 231,404 | 6.5% | |
Long term debt | Rs m | 0 | 1,278 | 0.0% | |
Total assets | Rs m | 20,684 | 315,799 | 6.5% | |
Interest coverage | x | 12.5 | 43.4 | 28.7% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.8 | 137.2% | |
Return on assets | % | 7.5 | 14.7 | 51.1% | |
Return on equity | % | 9.2 | 19.5 | 47.4% | |
Return on capital | % | 13.6 | 26.6 | 51.1% | |
Exports to sales | % | 26.7 | 52.2 | 51.2% | |
Imports to sales | % | 0 | 16.8 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 128,803 | 4.6% | |
Imports (cif) | Rs m | NA | 41,484 | 0.0% | |
Fx inflow | Rs m | 5,930 | 128,803 | 4.6% | |
Fx outflow | Rs m | 6,052 | 41,484 | 14.6% | |
Net fx | Rs m | -122 | 87,319 | -0.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 58,875 | 2.1% | |
From Investments | Rs m | -1,200 | -41,373 | 2.9% | |
From Financial Activity | Rs m | -41 | -26,861 | 0.2% | |
Net Cashflow | Rs m | -18 | -9,073 | 0.2% |
Indian Promoters | % | 48.2 | 26.7 | 180.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 47.4 | 3.6% | |
FIIs | % | 1.4 | 29.1 | 4.8% | |
ADR/GDR | % | 0.0 | 15.4 | - | |
Free float | % | 51.8 | 58.0 | 89.3% | |
Shareholders | 130,003 | 255,500 | 50.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES SUPRIYA LIFESCIENCE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Dr. Reddys | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | 4.47% | 0.97% |
1-Month | 5.64% | 1.47% | 2.08% |
1-Year | -1.14% | 28.54% | 55.37% |
3-Year CAGR | -12.91% | 7.04% | 15.04% |
5-Year CAGR | 16.34% | 16.28% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Dr. Reddys share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Dr. Reddys.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Dr. Reddys.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.